Printer Friendly

Browse Pyrazinamide topic


1-27 out of 27 article(s)
Title Author Type Date Words
Anti-TB drugs shortage. Mar 13, 2019 289
Synthesis, Characterization and Anticancer Activity of Pyrazine-2-Carboxamide Metal Complexes. Report Aug 31, 2018 4489
Protective role of taurine against hepatotoxicity induced by pyrazinamide in rats. Taziki, Shohreh; Khori, Vahid; Jahanshahi, Mehrdad; Seifi, Akhtar; Babakordi, Fatemeh Babakordi; Nik Report Jun 1, 2018 2664
Comparison of sputum-culture conversion for Mycobacterium bovis and M. tuberculosis. Scott, Colleen; Cavanaugh, Joseph S.; Silk, Benjamin J.; Ershova, Julia; Mazurek, Gerald H.; LoBue, Mar 1, 2017 4406
pncA gene mutations associated with pyrazinamide resistance in drug-resistant tuberculosis, South Africa and Georgia. Allana, Salim; Shashkina, Elena; Mathema, Barun; Bablishvili, Nino; Tukvadze, Nestani; Shah, N. Sari Mar 1, 2017 3416
Using Reduced Inoculum Densities of Mycobacterium tuberculosis in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation. Morlock, Glenn P.; Tyrrell, Frances C.; Baynham, Dorothy; Escuyer, Vincent E.; Green, Nicole; Kim, Y Jan 1, 2017 7092
Multidrug-resistant tuberculosis in Europe, 2010-2011. Gunther, Gunar; van Leth, Frank; Alexandru, Sofia; Altet, Neus; Avsar, Korkut; Bang, Didi; Barbuta, Mar 1, 2015 6123
New drugs for TB. Aug 1, 2012 275
Recent developments in treatment of latent tuberculosis infection. Menzies, Dick; Jahdali, Hamdan Al; Otaibi, Badriah Al Report Mar 1, 2011 6665
Comparison of MGIT 960 & pyrazinamidase activity assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Sharma, Babita; Pal, Nita; Malhotra, Bharti; Vyas, Leela; Rishi, Suman Report Jul 1, 2010 2742
Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment. Hoek, K.G.P.; Schaaf, H.S.; van Pittius, N.C. Gey; van Helden, P.D.; Warren, R.M. Clinical report Nov 1, 2009 2227
Intestinal barrier function and serum concentrations of rifampin, isoniazid\ and pyrazinamide in patients with pulmonary tuberculosis. Facanha, Monica C.; Gondim, Argina M.B.; Pinheiro, Valeria G.F.; Barroso, Elizabeth C.; Peloquin, Ch May 1, 2009 5686
Pharmacokinetics of pyrazinamide in children with primary progressive disease of lungs. Arya, D.S.; Ojha, S.K.; Semwal, O.P.; Nandave, M. Nov 1, 2008 3624
Latent TB treatment warning. (tuberculosis). Worcester, Sharon Brief Article Sep 15, 2003 210
Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. Aug 8, 2003 2782
Major side effects of TB drugs. Worcester, Sharon Brief Article Jul 15, 2003 193
Latent TB treatment. (Clinical Capsules). Worcester, Sharon Brief Article Mar 15, 2003 234
Short-course TB therapy raises compliance, risks. (Completion of Regimen May Outweigh Risks). Kirn, Timothy F. Jan 15, 2003 559
Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection. (Public Health Dispatch). Nov 8, 2002 570
Daily observed tuberculosis Tx for 2 weeks works. (Then Twice Weekly Tx for 24 Weeks). Kubetin, Sally Koch Brief Article Jun 1, 2002 269
TB Treatment, Liver Injury. Worcester, Sharon Brief Article Oct 1, 2001 246
Tuberculosis: Guidelines Changed for Latent TB Treatment. Brief Article Sep 21, 2001 211
Fatal and Severe Hepatitis Associated With Rifampin and Pyrazinamide for the Treatment of Latent Tuberculosis Infection -- New York and Georgia, 2000. Apr 20, 2001 1253
Head Off TB Resistance With Four-Drug Combo. WALSH, NANCY Brief Article Jun 15, 2000 559
Short-Course TB Prevention. Brief Article May 1, 2000 125
Use of Short-Course Tuberculosis Preventive Therapy Regimens in HIV-Seronegative Persons. Brief Article Oct 30, 1998 282
Penetrating the secrets of tuberculosis. Sternberg, Steve Jun 15, 1996 733

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters